ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.00%
Brent Oil
72.72
0.00%
Bitcoin
96,768.21
-0.45%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Uniqure Nv (0EE0) Cotización

Uniqure Nv

Uniqure Nv (0EE0)

LSE
31.50
0.00
(0.00%)
Cerrado 22 Diciembre 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
31.50
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
20,278
0.00 Rango del Día 0.00
31.50 Rango de 52 semanas 31.50
Capitalización de Mercado [m]
1.507B
Precio Anterior
31.50
Precio de Apertura
-
Hora
100
@
17.4
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
14,811
Acciones en circulación
47,834,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.64
Beneficio por acción (BPA)
-6.45
turnover
21.9M
Beneficio neto
-308.48M

Acerca de Uniqure Nv

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.uniqure.com
Sede
Amsterdam, North Holland, Nld
Fundado
-
Uniqure Nv is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0EE0. The last closing price for Uniqure Nv was US$31.50. Over the last year, Uniqure Nv shares have traded in a share price range of US$ 31.50 to US$ 31.50.

Uniqure Nv currently has 47,834,000 shares in issue. The market capitalisation of Uniqure Nv is US$1.51 billion. Uniqure Nv has a price to earnings ratio (PE ratio) of -2.64.

0EE0 Últimas noticias

Más noticias

uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease

uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease ~ U.S. Food and Drug Administration (FDA) agrees that data from ongoing...

10 Diciembre 2024
UK Regulatory

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy LEXINGTON, Mass. and AMSTERDAM, Nov. 21...

21 Noviembre 2024
UK Regulatory

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress ~ Type B meeting scheduled with the FDA in the fourth quarter of 2024 to initiate discussions...

05 Noviembre 2024
UK Regulatory

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) -- uniQure N.V...

15 Octubre 2024
UK Regulatory

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a...

23 Septiembre 2024
UK Regulatory

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Aug. 15, 2024 (GLOBE NEWSWIRE) -- uniQure...

15 Agosto 2024
UK Regulatory

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update ~ Announced RMAT designation for AMT-130 in Huntington’s disease and positive interim Phase I/II data...

01 Agosto 2024
UK Regulatory

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen ~ uniQure maintains preferential access to industry-leading manufacturing capabilities to support its pipeline of gene...

23 Julio 2024
UK Regulatory

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease ~ Achieved statistically significant...

09 Julio 2024
UK Regulatory

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen ~ Proposed divestiture streamlines uniQure’s focus and represents an important milestone in its ongoing effort to...

01 Julio 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10031.531.531.5793731.5DE
40031.531.531.52902531.5DE
120031.531.531.51481131.5DE
260031.531.531.51570331.5DE
520031.531.531.5863031.5DE
1560031.531.531.5319131.5DE
2600031.531.531.5201831.5DE

0EE0 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Uniqure Nv?
El precio actual de las acciones de Uniqure Nv es US$ 31.50
¿Cuántas acciones de Uniqure Nv están en circulación?
Uniqure Nv tiene 47,834,000 acciones en circulación
¿Cuál es la capitalización de mercado de Uniqure Nv?
La capitalización de mercado de Uniqure Nv es USD 1.51B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Uniqure Nv?
Uniqure Nv ha negociado en un rango de US$ 31.50 a US$ 31.50 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Uniqure Nv?
El ratio precio/beneficio de Uniqure Nv es -2.64
¿Cuál es el ratio de efectivo a ventas de Uniqure Nv?
El ratio de efectivo a ventas de Uniqure Nv es 37.17
¿Cuál es la moneda de reporte de Uniqure Nv?
Uniqure Nv presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Uniqure Nv?
El último ingresos anual de Uniqure Nv es USD 21.9M
¿Cuál es el último beneficio anual de Uniqure Nv?
El último beneficio anual de Uniqure Nv es USD -308.48M
¿Cuál es la dirección registrada de Uniqure Nv?
La dirección registrada de Uniqure Nv es PAASHEUVELWEG 25A, AMSTERDAM, NORTH HOLLAND, 1105 BP
¿Cuál es la dirección del sitio web de Uniqure Nv?
La dirección del sitio web de Uniqure Nv es www.uniqure.com
¿En qué sector industrial opera Uniqure Nv?
Uniqure Nv opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TIRTiger Royalties And Investments Plc
0.15p
(50.00%)
3.41M
BAYBay Capital Plc
5.50p
(19.57%)
209.68k
MASTMast Energy Developments Plc
0.19p
(18.75%)
20.09M
MHNMenhaden Resource Efficiency Plc
148.50p
(18.33%)
1M
ZENZenith Energy Ltd.
2.50p
(16.28%)
3.93M
TRYBTribe Technology Plc
0.115p
(-79.09%)
24.27M
NMTNeometals Ltd
2.75p
(-35.29%)
49.4k
SNGSynairgen Plc
2.46p
(-34.31%)
4.31M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M
AYMAnglesey Mining Plc
0.70p
(-17.65%)
2.99M
NTVONativo Resources Plc
0.002p
(5.26%)
971.94M
TRPTower Resources Plc
0.035p
(9.38%)
620.03M
LLOYLloyds Banking Group Plc
54.16p
(-0.26%)
341.48M
ORCPOracle Power Plc
0.0255p
(-1.92%)
192.93M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M

Discusión

Ver feed completo
copytele copytele 7 minutos hace
GAVE YOU # 25
RGTI
Zorax Zorax 13 minutos hace
The reality is shitface offered him a deal he couldn't refuse. A government job.
ReasearchThis ReasearchThis 19 minutos hace
I really think AXXA Bashers should study in detail.
AXXA's new business plan. In quotes
AXXA has been
"Grossly overlooked
Formally updated company kickbacks
Yearly outstanding updated receipts
Systematically experiencing lasting financials"
AXXA
Think1st Think1st 21 minutos hace
https://finance.yahoo.com/news/exclusive-u-data-center-power-150910487.html
LWLG
devil dog 96 devil dog 96 23 minutos hace
So you think issuing restricted shares that can't have their restriction lifted for another year is how they plan on scamming us when they have had shares restricted that were issued in 2018 that the restriction can be lifted today? You sound like you don't know how the OTC works 🤡 LMAO
ATMH
One11 One11 28 minutos hace
Shoon and Steal ride again! Hi ho!!!
Up the breakout boards we go, ho ho!
Not too smart, not too bright but Shoon and Steal will stay and fight, hi dee ho!
MGON
shajandr shajandr 29 minutos hace
When DAVE MASSEY returns from his extended-stay North Korean intox centers, expect him to kick Brad to DaCurb and retool SIRC's binniss plann to focus on energy drinks, power bars, and lithium/rare earths mining ops. Also expect DAVE to create a new SIRC subsidiary that will build and operate a chai
SIRC
copytele copytele 29 minutos hace
https://youtu.be/cQ7qqzQGHs4
RGTI
Not likely Not likely 33 minutos hace
So at the end of the year you pumpers just add 1 to satisfy your hope?
SPZI
Not likely Not likely 42 minutos hace
If Timmy brings in a 'Chinese' company. It will most certainly be a scam.

OTC is absolutely riddled with 'Chinese opportunities'. Always has been.

The 'go to' with OTC scams.


Can't verify or prove it.
EEGI
Flobewan Flobewan 42 minutos hace
OMG I'm watching Life Liberty & Levin Saturday night, if you missed. it MAkE SURE you catch the repeat on Sunday. Fox
knrorrel knrorrel 43 minutos hace
https://investorshub.advfn.com/NVNI-Group-Ltd-NVNI-42672
NVNI
knrorrel knrorrel 44 minutos hace
$NVNI monday $20 or $77 ?? 🔥🔥🔥🔥 When the entry comes, it always looks like real money is flowing in , that's awesome 🔥🔥🔥🔥🔥🔥

all only imho



NVNI
knrorrel knrorrel 45 minutos hace
$NVNI monday $20 or $77 ?? 🔥🔥🔥🔥 When the entry comes, it always looks like real money is flowing in , that's awesome 🔥🔥🔥🔥🔥🔥

all only imho

NVNI
Genz2 Genz2 46 minutos hace
https://www.cnbc.com/amp/2024/12/21/cruise-line-offers-unlimited-pass-for-120000you-can-pay-in-bitcoin.html

Wouldn’t your family rather have a Cybertruck, or a model 3 performance with a powerwall and solar panels?? Save the environment or go on a big boat polluting the earth - gee I
firebag1 firebag1 46 minutos hace
MUMBLE
HMBL
mzasif mzasif 47 minutos hace
I believe anything with Bird flu virus has a direction connection to AEMD
Read this from Friday...
https://ih.advfn.com/stock-market/NASDAQ/aethlon-medical-AEMD/stock-news/95139713/aethlon-medical-provides-update-on-the-ability-of

https://stocktwits.com/symbol/AEMD
AEMD
knrorrel knrorrel 48 minutos hace
here again the unique IBM news with $QNCCF as a reminder.
https://finance.yahoo.com/news/quantum-emotion-partners-platform-digital-132300381.html


QNCCF

Su Consulta Reciente

LSE
0EE0
Uniqure Nv
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados